- seekingalpha.com
- Posted On 11 November 2026
TELA Bio outlines $76M-$78M 2027 expense range following $17M cost reduction plan (NASDAQ:TELA)
Earnings Call Insights TELA Bio outlines $76M-$78M 2027 expense range following $17M cost reduction plan Nov 10, 2026, 7:32 PM ET TELA Bio, Inc. (TELA) Stock AI...
Source:
seekingalpha.com